Access to this page has been denied because we believe that you are using automation tools to navigate the website. Then, with Congress stuck on almost everything, Cannabis shares faltered and fell into disrepair. At the moment, there are a couple of problems for cannabis companies that make the prospect of selling especially attractive. If you're seeing a red wall in the investment account where you hold your cannabis shares and you're wondering if you've made a series of terrible mistakes, you're not alone.
Only Trulieve Cannabis (TCNNF 3.91%) is still seeing significantly higher sales than a year ago. For more coverage on cannabis stocks, including my best options, consider subscribing to the Cannabis Growth Portfolio. Subscribe to The Cannabis Growth Portfolio for exclusive coverage of the cannabis industry, including a portfolio of models and real-time buy and sell alerts. All cannabis stocks fell when optimism for federal legalization reached a peak following the Democrats' victories in the Senate and the White House early last year.
The cannabis sectors have been in a downtrend for quite some time, but the decline in the ACB is something different. The names are trading very cheaply with solid fundamentals. I have positioned the cannabis growth portfolio to focus on U. Viridian Capital Advisors, a New York financial and strategic advisory firm dedicated to the cannabis market, published a report this month outlining its forecasts for the United States.
Worse still, with rising inflation and consumer portfolios looking too scarce to justify spending money on cannabis, there isn't necessarily a big recovery to expect in the short term. Possible reasons for this compression include concerns about slowing growth due to delays in creating new recreational cannabis markets in New Jersey and New York, and price pressure in still-developing markets, such as Arizona, Illinois, Massachusetts and Michigan. For emerging industries, such as cannabis, that's bad news, as it means that companies will have to bear higher interest expenses in the future if they want to borrow money to expand. Subscribers have access to the model portfolio, cannabis industry research panels, real-time updates and more.
The other disadvantage is that this is not exactly a favorable market environment for cannabis growers seeking funding to issue new shares, since their stock prices are considerably lower than before. Before there is significant institutional investment, federal legislation must be passed that gives the cannabis industry access to the U.